BioLineRx to Raise $6M through Direct Offering
Monday, 1 April 2024, 13:14
BioLineRx Plans $6M Fundraising through Direct Offering
BioLineRx intends to raise $6M by offering 7.5M American depositary shares and warrants at a combined purchase price of $0.80 per ADS.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.